[Veco Cup] Bangce Medical participated in the "Veco Cup OFweek 2023 China Robotics Industry Annual Investment Value Enterprise Award"

OFweek Cup · OFweek 2023 China Robot Industry Annual Selection (abbreviated as OFweek Robot Awards 2023) is jointly organized by OFweek, China's high-tech industry portal, and its authoritative robot professional media - OFweek Robot. This selection is a major brand event in China's robot industry and one of the most professional and influential selections in the high-tech industry.

The event aims to build a brand communication and display platform for products, technologies and companies in the robotics industry, and leverage the resources and influence of the OFweek platform to promote innovative products and solutions to industry users and the market, encouraging more companies to invest in technological innovation; at the same time, it will deliver more innovative products and cutting-edge technologies to the industry, and together imagine the future of the robotics industry.

The OFweek Robot Awards 2023, the annual selection of China's robot industry, will enter the online voting stage from February 20 to March 20, 2024, and the award ceremony will be held in Shenzhen on April 18. At present, the event is in the hot stage of enterprise application, and enterprises in the industry have responded positively.

Pound Policy Medical Participated in the "Veco Cup OFweek 2023 China Robotics Industry Annual Investment Value Enterprise Award"

Award: Veken Cup OFweek 2023 China Robotics Industry Annual Investment Value Enterprise Award

Participating companies: Bangkece (Shanghai) Intelligent Medical Technology Co., Ltd.

Company Introduction:

Puncture (Shanghai) Robotic Co.LTD is a subsidiary of HIT Robotics (000584.SZ), a listed company in the HIT Robotics System, focusing on medical robots . Its headquarters is located in Shanghai. As an innovative Medtech company, Puncture is determined to be an enabler of medical precision and create products that empower doctors and benefit patients. With continuous innovation of "technical products" as its core competitiveness, it takes the continuous shaping of "technology-driven, technology platform-based, and specialized solutions" as its corporate development strategy.

The team studies the common clinical characteristics of various diseases, explores common clinical needs that need to be addressed, and applies advanced robotics technology to create more specialized robots for niche areas. Currently, the core application products cover medical aesthetics, tumors and other diagnosis and treatment links. While helping the "clinical procedure standards" to be implemented quickly and effectively, patients can enjoy the precise and efficient clinical effects brought by high-end medical technology. Bangce will continue to create better equipment and conditions for medical services, let high-end technology serve all mankind, and become a pioneer in high-end medical technology innovation services and a leading medical robot company.

Reasons for participation:

As an innovative Medtech company, Bangce is determined to be an enabler of medical precision and create products that empower doctors and benefit patients. It takes continuous innovation of "technological products" as its core competitiveness and constantly shapes "technology-driven, technology platform-based, and specialized solutions" as its corporate development strategy.

Bangce Medical is an innovative enterprise incubated by the Harbin Institute of Technology Robotics System, which focuses on surgical robots and provides systematic specialized medical solutions for common clinical needs. Since its establishment in 2019, the company has completed four rounds of financing, with a total financing amount of nearly 100 million yuan, and has applied for more than 100 intellectual property rights.

Voting time:

The voting for this year's "OFweek Robot Awards 2023" event will begin on February 20. Please pay attention to the robot-related selection news on Veken.com and you are welcome to vote.